Lobbying

Elsevier's latest lobbying report covers Q1 2025, at $20K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid.

Elsevier

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Elsevier lobbying by quarter
Elsevier lobbying by quarter
QuarterAmountReports
Q4 2022$20K1
Q1 2023$20K1
Q2 2023$20K1
Q3 2023$20K1
Q4 2023$20K1
Q1 2024$20K1
Q2 2024$20K1
Q3 2024$20K1
Q4 2024$20K1
Q1 2025$20K1
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Medicare and Medicaid$200K · 10 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)10 reports
  • Health & Human Services, Dept of (HHS)10 reports
  • HOUSE OF REPRESENTATIVES10 reports
  • SENATE10 reports

Firms it paid

Firm
Health Policy Source$200K10 quarters

Former officials lobbying for it

Former position
DANIEL TYLER BOSTONHealth Policy Director, House Energy & Commerce; Deputy Chief of Staff & Spokesperson for Congresswoman Sue Kelly; Policy Advisory & Communications Director for Congressman Joe Knollenberg; Communications Advisor for Senator Mitch McConnellQ1 2025
GAYLE GERDESLegislative Correspondent: Senator Timothy Hutchison; Legislative Assistant: Congressman Chris John; Intern: Congressman Jim McCrery and Congressman Cleo FieldsQ1 2025

Lobbying reports

Filed by
25/04/10for Q1 2025Health Policy Source$20K
25/01/21for Q4 2024Health Policy Source$20K
24/10/16for Q3 2024Health Policy Source$20K
24/07/22for Q2 2024Health Policy Source$20K
24/04/18for Q1 2024Health Policy Source$20K
24/01/17for Q4 2023Health Policy Source$20K
23/10/17for Q3 2023Health Policy Source$20K
23/07/18for Q2 2023Health Policy Source$20K
23/04/19for Q1 2023Health Policy Source$20K
23/01/18for Q4 2022Health Policy Source$20K